MM Packaging, a specialist in secondary packaging for the pharmaceutical sector, is set to showcase its comprehensive clinical trial solutions at Clinical Trial Supply (CTS) Europe 2025, scheduled for 25-26 February at the Hyatt Regency Barcelona Tower, Spain.
As Europe’s leading conference for pharmaceutical and biotechnology professionals, CTS Europe will bring together over 500 attendees, 55 exhibitors, and 30 speakers to explore innovations in clinical supply chain management, discuss regulatory updates, and share best practices for optimizing operations.
At Table 20, visitors can discover MM Packaging’s extensive range of clinical trial packaging solutions, including booklet labels, tamper-evident labels, cryogenic labels, clinical literature, and blinding solutions. The company’s presence at the event highlights its ongoing commitment to advancing pharmaceutical innovation through cutting-edge packaging design.
MM Packaging experts, including Joe Monteiro, Key Account Manager, and Diarmuid Wilson, Managing Director at MM Glasnevin, will be on hand throughout the event to discuss how the company’s tailored solutions can meet the specific needs of clinical studies.
Joe Monteiro commented, “In clinical trials, every detail matters – particularly in labelling and packaging. We have the culture, processes, and security systems in place to ensure that every label and carton adheres to the highest standards of accuracy, compliance, and security. Our focus on precision ensures patient safety, upholds regulatory standards, and preserves the integrity of investigational medicinal products (IMP).”
With over 30 years of experience in designing and manufacturing IMP labels, MM Packaging has developed robust quality systems that make it a leading supplier in the clinical trial sector. All printed components are produced in pharmaceutical manufacturing facilities certified to the stringent PS 9000:2011 standards. Additionally, the company is expanding its clinical trial capabilities at its Dublin plant, MM Packaging Glasnevin, demonstrating its proactive approach to adapting to evolving market needs.
